CA
IBB icon

Commerzbank Aktiengesellschaft’s iShares Biotechnology ETF IBB Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,090
Closed -$1.7M – 578
2019
Q4 		$1.7M Sell
14,090
-254,180
-95% -$28.4M 0.02% 362
2019
Q3 		$26.7M Sell
268,270
-47,894
-15% -$5.01M 0.2% 95
2019
Q2 		$34.5M Sell
316,164
-21,780
-6% -$2.32M 0.27% 75
2019
Q1 		$37.8M Buy
337,944
+51,227
+18% +$5.62M 0.34% 62
2018
Q4 		$27.6M Sell
286,717
-363,390
-56% -$38.6M 0.28% 68
2018
Q3 		$79.3M Buy
650,107
+64,031
+11% +$7.54M 0.69% 30
2018
Q2 		$64.4M Buy
586,076
+205,770
+54% +$22M 0.61% 32
2018
Q1 		$40.6M Buy
380,306
+85,499
+29% +$9.48M 0.42% 51
2017
Q4 		$31.5M Sell
294,807
-44,796
-13% -$4.79M 0.36% 61
2017
Q3 		$37.8M Buy
339,603
+149,028
+78% +$15.9M 0.5% 40
2017
Q2 		$19.7M Sell
190,575
-22,638
-11% -$2.23M 0.33% 70
2017
Q1 		$20.8M Buy
213,213
+3,612
+2% +$346K 0.31% 73
2016
Q4 		$18.5M Buy
209,601
+58,803
+39% +$5.35M 0.27% 81
2016
Q3 		$14.6M Buy
150,798
+46,740
+45% +$4.45M 0.23% 87
2016
Q2 		$8.93K Buy
104,058
+4,686
+5% +$420K 0.06% 175
2016
Q1 		$8.64M Buy
99,372
+67,149
+208% +$6M 0.07% 159
2015
Q4 		$3.63M Buy
32,223
+10,323
+47% +$1.12M 0.03% 365
2015
Q3 		$2.21M Sell
21,900
-3,243
-13% -$389K 0.02% 419
2015
Q2 		$3.09M Buy
25,143
+2,388
+10% +$286K 0.02% 481
2015
Q1 		$2.6M Buy
22,755
+5,520
+32% +$609K 0.02% 536
2014
Q4 		$1.74M Hold
17,235
– – 0.01% 703
2014
Q3 		$1.57M Sell
17,235
-16,803
-49% -$1.47M 0.01% 778
2014
Q2 		$2.92M Sell
34,038
-41,136
-55% -$3.24M 0.01% 621
2014
Q1 		$5.92M Buy
+75,174
New +$6.26M 0.03% 397
2013
Q3 		– Sell
-20,373
Closed -$1.18M – 1351
2013
Q2 		$1.18M Buy
+20,373
New +$1.18M 0.01% 895

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerzbank Aktiengesellschaft's IBB Position: Q1 2020 in Review

Commerzbank Aktiengesellschaft sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 14,090 shares — an estimated $1.7M sold.

Commerzbank Aktiengesellschaft first reported a position in IBB in Q2 2013 and held it in 25 quarters. The position peaked at $79.3M in Q3 2018. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

  • Commerzbank Aktiengesellschaft reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 14,090 iShares Biotechnology ETF shares in Q1 2020, an estimated $1.7M.
  • Commerzbank Aktiengesellschaft first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 25 quarters.
  • Commerzbank Aktiengesellschaft's iShares Biotechnology ETF position peaked at $79.3M in Q3 2018.
  • 668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2020, filed 29 Apr 2020.